Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0B4WR
|
||||
Former ID |
DNC012031
|
||||
Drug Name |
2-Isoxazol-5-yl-3H-imidazo[4,5-c]quinoline
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C13H8N4O
|
||||
Canonical SMILES |
C1=CC=C2C(=C1)C3=NC(=C4C=CNO4)N=C3C=N2
|
||||
InChI |
1S/C13H8N4O/c1-2-4-9-8(3-1)12-10(7-14-9)16-13(17-12)11-5-6-15-18-11/h1-7,15H/b13-11-
|
||||
InChIKey |
DUIZUGINLYIMFH-QBFSEMIESA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Gamma-aminobutyric acid receptor subunit alpha-1 | Target Info | Inhibitor | [1] | |
Gamma-aminobutyric acid receptor subunit beta-2 | Target Info | Inhibitor | [1] | ||
Gamma-aminobutyric acid receptor subunit gamma-2 | Target Info | Inhibitor | [1] | ||
Gamma-aminobutyric acid receptor | Target Info | Inhibitor | [1] | ||
KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
Retrograde endocannabinoid signaling | |||||
GABAergic synapse | |||||
Morphine addiction | |||||
Nicotine addictionhsa04080:Neuroactive ligand-receptor interaction | |||||
Serotonergic synapse | |||||
Nicotine addiction | |||||
Reactome | Ligand-gated ion channel transport | ||||
GABA A receptor activationR-HSA-975298:Ligand-gated ion channel transport | |||||
GABA A receptor activation | |||||
WikiPathways | SIDS Susceptibility Pathways | ||||
Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell | |||||
Iron uptake and transportWP2754:Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell | |||||
Iron uptake and transport | |||||
References | |||||
REF 1 | J Med Chem. 1996 Jul 5;39(14):2844-51.Synthesis and structure--activity relationships of fused imidazopyridines: a new series of benzodiazepine receptor ligands. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.